BioXcel Therapeutics
BTAI
BTAI
34 hedge funds and large institutions have $1.19M invested in BioXcel Therapeutics in 2025 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 6 increasing their positions, 8 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
1.15% less ownership
Funds ownership: 11.52% → 10.37% (-1.2%)
25% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 8
Holders
34
Holding in Top 10
–
Calls
$15K
Puts
$4K
Top Buyers
| 1 | +$437K | |
| 2 | +$102K | |
| 3 | +$77.7K | |
| 4 |
Jones Financial Companies
Des Peres,
Missouri
|
+$46K |
| 5 |
HighTower Advisors
Chicago,
Illinois
|
+$44.5K |
Top Sellers
| 1 | -$112K | |
| 2 | -$100K | |
| 3 | -$50.3K | |
| 4 |
VF
Virtu Financial
New York
|
-$22K |
| 5 |
BlackRock
New York
|
-$9.89K |
